AU2021101165A4 - Mushroom oil drops and its preparation method - Google Patents
Mushroom oil drops and its preparation method Download PDFInfo
- Publication number
- AU2021101165A4 AU2021101165A4 AU2021101165A AU2021101165A AU2021101165A4 AU 2021101165 A4 AU2021101165 A4 AU 2021101165A4 AU 2021101165 A AU2021101165 A AU 2021101165A AU 2021101165 A AU2021101165 A AU 2021101165A AU 2021101165 A4 AU2021101165 A4 AU 2021101165A4
- Authority
- AU
- Australia
- Prior art keywords
- oil
- olive oil
- probiotics
- tea polyphenols
- chain triglycerides
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 20
- 239000001188 FEMA 4487 Substances 0.000 title 1
- 239000006041 probiotic Substances 0.000 claims abstract description 68
- 235000018291 probiotics Nutrition 0.000 claims abstract description 68
- 229940057917 medium chain triglycerides Drugs 0.000 claims abstract description 52
- 239000004006 olive oil Substances 0.000 claims abstract description 50
- 239000003921 oil Substances 0.000 claims abstract description 49
- 235000019198 oils Nutrition 0.000 claims abstract description 49
- 235000008390 olive oil Nutrition 0.000 claims abstract description 49
- 230000000529 probiotic effect Effects 0.000 claims abstract description 23
- 239000000126 substance Substances 0.000 claims abstract description 11
- 239000002994 raw material Substances 0.000 claims abstract description 10
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 9
- 244000269722 Thea sinensis Species 0.000 claims description 57
- 235000013824 polyphenols Nutrition 0.000 claims description 56
- 150000008442 polyphenolic compounds Chemical class 0.000 claims description 54
- 239000000203 mixture Substances 0.000 claims description 26
- 230000000694 effects Effects 0.000 claims description 23
- 238000002156 mixing Methods 0.000 claims description 22
- 239000000047 product Substances 0.000 claims description 14
- 238000000034 method Methods 0.000 claims description 11
- 239000012467 final product Substances 0.000 claims description 10
- 230000001954 sterilising effect Effects 0.000 claims description 9
- 238000004659 sterilization and disinfection Methods 0.000 claims description 9
- 238000001816 cooling Methods 0.000 claims description 7
- 239000000843 powder Substances 0.000 claims description 7
- 239000002245 particle Substances 0.000 claims description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 6
- 238000003756 stirring Methods 0.000 claims description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 abstract description 22
- 239000008280 blood Substances 0.000 abstract description 17
- 210000004369 blood Anatomy 0.000 abstract description 17
- 235000021281 monounsaturated fatty acids Nutrition 0.000 abstract description 8
- 230000009286 beneficial effect Effects 0.000 abstract description 7
- 150000002632 lipids Chemical class 0.000 abstract description 7
- 235000012000 cholesterol Nutrition 0.000 abstract description 6
- 235000013343 vitamin Nutrition 0.000 abstract description 6
- 239000011782 vitamin Substances 0.000 abstract description 6
- 229940088594 vitamin Drugs 0.000 abstract description 6
- 229930003231 vitamin Natural products 0.000 abstract description 6
- 238000009825 accumulation Methods 0.000 abstract description 5
- 230000002526 effect on cardiovascular system Effects 0.000 abstract description 5
- 230000006870 function Effects 0.000 abstract description 5
- 208000024172 Cardiovascular disease Diseases 0.000 abstract description 4
- 208000026106 cerebrovascular disease Diseases 0.000 abstract description 3
- 235000013616 tea Nutrition 0.000 description 57
- 230000036541 health Effects 0.000 description 36
- 241000894006 Bacteria Species 0.000 description 21
- 210000000936 intestine Anatomy 0.000 description 19
- 230000036039 immunity Effects 0.000 description 15
- 238000011156 evaluation Methods 0.000 description 14
- 239000003925 fat Substances 0.000 description 14
- 235000019197 fats Nutrition 0.000 description 14
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 14
- 210000002784 stomach Anatomy 0.000 description 14
- 230000002708 enhancing effect Effects 0.000 description 12
- 230000001105 regulatory effect Effects 0.000 description 12
- 238000005728 strengthening Methods 0.000 description 12
- 230000000968 intestinal effect Effects 0.000 description 10
- 241000519995 Stachys sylvatica Species 0.000 description 9
- 210000001035 gastrointestinal tract Anatomy 0.000 description 9
- 230000001953 sensory effect Effects 0.000 description 9
- 241001465754 Metazoa Species 0.000 description 8
- 230000003064 anti-oxidating effect Effects 0.000 description 8
- 239000000306 component Substances 0.000 description 8
- 230000002401 inhibitory effect Effects 0.000 description 8
- 230000035943 smell Effects 0.000 description 8
- 230000003078 antioxidant effect Effects 0.000 description 7
- 150000001765 catechin Chemical class 0.000 description 7
- 239000004310 lactic acid Substances 0.000 description 7
- 235000014655 lactic acid Nutrition 0.000 description 7
- 244000005700 microbiome Species 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- 230000001580 bacterial effect Effects 0.000 description 6
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 6
- 235000005487 catechin Nutrition 0.000 description 6
- 235000015097 nutrients Nutrition 0.000 description 6
- 241000894007 species Species 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- 238000011282 treatment Methods 0.000 description 6
- 241000218588 Lactobacillus rhamnosus Species 0.000 description 5
- 239000003963 antioxidant agent Substances 0.000 description 5
- 235000006708 antioxidants Nutrition 0.000 description 5
- 235000013305 food Nutrition 0.000 description 5
- 150000003254 radicals Chemical class 0.000 description 5
- 235000003441 saturated fatty acids Nutrition 0.000 description 5
- 150000004671 saturated fatty acids Chemical class 0.000 description 5
- 241000186012 Bifidobacterium breve Species 0.000 description 4
- WMBWREPUVVBILR-UHFFFAOYSA-N GCG Natural products C=1C(O)=C(O)C(O)=CC=1C1OC2=CC(O)=CC(O)=C2CC1OC(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-UHFFFAOYSA-N 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 230000003712 anti-aging effect Effects 0.000 description 4
- 210000004204 blood vessel Anatomy 0.000 description 4
- 210000001072 colon Anatomy 0.000 description 4
- 230000000052 comparative effect Effects 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 235000016709 nutrition Nutrition 0.000 description 4
- -1 polyphenol compounds Chemical class 0.000 description 4
- 235000000346 sugar Nutrition 0.000 description 4
- 235000019640 taste Nutrition 0.000 description 4
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 4
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 4
- 201000001320 Atherosclerosis Diseases 0.000 description 3
- 241000186000 Bifidobacterium Species 0.000 description 3
- 241000901050 Bifidobacterium animalis subsp. lactis Species 0.000 description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 3
- 206010012735 Diarrhoea Diseases 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 241000282412 Homo Species 0.000 description 3
- 244000199866 Lactobacillus casei Species 0.000 description 3
- 241000194017 Streptococcus Species 0.000 description 3
- 230000001093 anti-cancer Effects 0.000 description 3
- 230000003471 anti-radiation Effects 0.000 description 3
- 244000052616 bacterial pathogen Species 0.000 description 3
- 229940009289 bifidobacterium lactis Drugs 0.000 description 3
- 235000019658 bitter taste Nutrition 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 230000007423 decrease Effects 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 230000000813 microbial effect Effects 0.000 description 3
- 230000035764 nutrition Effects 0.000 description 3
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 description 3
- 239000002244 precipitate Substances 0.000 description 3
- 230000002265 prevention Effects 0.000 description 3
- 238000003672 processing method Methods 0.000 description 3
- 230000005855 radiation Effects 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- WMBWREPUVVBILR-WIYYLYMNSA-N (-)-Epigallocatechin-3-o-gallate Chemical compound O([C@@H]1CC2=C(O)C=C(C=C2O[C@@H]1C=1C=C(O)C(O)=C(O)C=1)O)C(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-WIYYLYMNSA-N 0.000 description 2
- 241000193830 Bacillus <bacterium> Species 0.000 description 2
- 235000003717 Boswellia sacra Nutrition 0.000 description 2
- 240000007551 Boswellia serrata Species 0.000 description 2
- 235000012035 Boswellia serrata Nutrition 0.000 description 2
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 2
- 241000194032 Enterococcus faecalis Species 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- 239000004863 Frankincense Substances 0.000 description 2
- 108010028554 LDL Cholesterol Proteins 0.000 description 2
- 244000199885 Lactobacillus bulgaricus Species 0.000 description 2
- 241001468157 Lactobacillus johnsonii Species 0.000 description 2
- 241000186869 Lactobacillus salivarius Species 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- 241000736262 Microbiota Species 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 208000008589 Obesity Diseases 0.000 description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 2
- 241000191967 Staphylococcus aureus Species 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 230000002019 anti-mutation Effects 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 230000000112 colonic effect Effects 0.000 description 2
- 208000002925 dental caries Diseases 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 210000002249 digestive system Anatomy 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- 208000001848 dysentery Diseases 0.000 description 2
- 239000008157 edible vegetable oil Substances 0.000 description 2
- 229940032049 enterococcus faecalis Drugs 0.000 description 2
- 230000029142 excretion Effects 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 210000003608 fece Anatomy 0.000 description 2
- 229930003935 flavonoid Natural products 0.000 description 2
- 235000017173 flavonoids Nutrition 0.000 description 2
- 150000002215 flavonoids Chemical class 0.000 description 2
- 235000012041 food component Nutrition 0.000 description 2
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 2
- LVJJFMLUMNSUFN-UHFFFAOYSA-N gallocatechin gallate Natural products C1=C(O)C=C2OC(C=3C=C(O)C(O)=CC=3)C(O)CC2=C1OC(=O)C1=CC(O)=C(O)C(O)=C1 LVJJFMLUMNSUFN-UHFFFAOYSA-N 0.000 description 2
- 235000009569 green tea Nutrition 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 230000007366 host health Effects 0.000 description 2
- 210000000987 immune system Anatomy 0.000 description 2
- 230000009916 joint effect Effects 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- 230000003859 lipid peroxidation Effects 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- 210000003470 mitochondria Anatomy 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 235000020824 obesity Nutrition 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 238000005502 peroxidation Methods 0.000 description 2
- 150000007965 phenolic acids Chemical class 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 230000008092 positive effect Effects 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 230000008439 repair process Effects 0.000 description 2
- 230000002000 scavenging effect Effects 0.000 description 2
- 210000000813 small intestine Anatomy 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 238000013112 stability test Methods 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- 150000003626 triacylglycerols Chemical class 0.000 description 2
- 235000015112 vegetable and seed oil Nutrition 0.000 description 2
- 239000008158 vegetable oil Substances 0.000 description 2
- 230000004580 weight loss Effects 0.000 description 2
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 1
- LSHVYAFMTMFKBA-PZJWPPBQSA-N (+)-catechin-3-O-gallate Chemical compound O([C@H]1CC2=C(O)C=C(C=C2O[C@@H]1C=1C=C(O)C(O)=CC=1)O)C(=O)C1=CC(O)=C(O)C(O)=C1 LSHVYAFMTMFKBA-PZJWPPBQSA-N 0.000 description 1
- WMBWREPUVVBILR-GHTZIAJQSA-N (+)-gallocatechin gallate Chemical compound O([C@H]1CC2=C(O)C=C(C=C2O[C@@H]1C=1C=C(O)C(O)=C(O)C=1)O)C(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-GHTZIAJQSA-N 0.000 description 1
- OHZCFWMJMWFNFP-ZVGUSBNCSA-L (2r,3r)-2,3-dihydroxybutanedioate;iron(2+) Chemical compound [Fe+2].[O-]C(=O)[C@H](O)[C@@H](O)C([O-])=O OHZCFWMJMWFNFP-ZVGUSBNCSA-L 0.000 description 1
- PHIQHXFUZVPYII-ZCFIWIBFSA-N (R)-carnitine Chemical compound C[N+](C)(C)C[C@H](O)CC([O-])=O PHIQHXFUZVPYII-ZCFIWIBFSA-N 0.000 description 1
- 206010060965 Arterial stenosis Diseases 0.000 description 1
- 208000004429 Bacillary Dysentery Diseases 0.000 description 1
- 244000063299 Bacillus subtilis Species 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- 241000606125 Bacteroides Species 0.000 description 1
- 241000186016 Bifidobacterium bifidum Species 0.000 description 1
- 241001608472 Bifidobacterium longum Species 0.000 description 1
- 241000186015 Bifidobacterium longum subsp. infantis Species 0.000 description 1
- BFWWFJGFAIZYNV-UHFFFAOYSA-N C1(=CC=CC=C1)C1OC2=CC=CC=C2CC1.O1C(CCC2=CC=CC=C12)C1=CC=CC=C1 Chemical compound C1(=CC=CC=C1)C1OC2=CC=CC=C2CC1.O1C(CCC2=CC=CC=C12)C1=CC=CC=C1 BFWWFJGFAIZYNV-UHFFFAOYSA-N 0.000 description 1
- 208000005623 Carcinogenesis Diseases 0.000 description 1
- 206010008631 Cholera Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 241001464948 Coprococcus Species 0.000 description 1
- 230000005778 DNA damage Effects 0.000 description 1
- 231100000277 DNA damage Toxicity 0.000 description 1
- 206010012742 Diarrhoea infectious Diseases 0.000 description 1
- 208000035240 Disease Resistance Diseases 0.000 description 1
- 241000588921 Enterobacteriaceae Species 0.000 description 1
- 241000186394 Eubacterium Species 0.000 description 1
- CITFYDYEWQIEPX-UHFFFAOYSA-N Flavanol Natural products O1C2=CC(OCC=C(C)C)=CC(O)=C2C(=O)C(O)C1C1=CC=C(O)C=C1 CITFYDYEWQIEPX-UHFFFAOYSA-N 0.000 description 1
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 241000605909 Fusobacterium Species 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 108010023302 HDL Cholesterol Proteins 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 208000022559 Inflammatory bowel disease Diseases 0.000 description 1
- 102000014150 Interferons Human genes 0.000 description 1
- 108010050904 Interferons Proteins 0.000 description 1
- 229910021578 Iron(III) chloride Inorganic materials 0.000 description 1
- XMOCLSLCDHWDHP-UHFFFAOYSA-N L-Epigallocatechin Natural products OC1CC2=C(O)C=C(O)C=C2OC1C1=CC(O)=C(O)C(O)=C1 XMOCLSLCDHWDHP-UHFFFAOYSA-N 0.000 description 1
- 241000186660 Lactobacillus Species 0.000 description 1
- 235000013960 Lactobacillus bulgaricus Nutrition 0.000 description 1
- 240000006024 Lactobacillus plantarum Species 0.000 description 1
- 201000010538 Lactose Intolerance Diseases 0.000 description 1
- 102000003820 Lipoxygenases Human genes 0.000 description 1
- 108090000128 Lipoxygenases Proteins 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- IOVCWXUNBOPUCH-UHFFFAOYSA-M Nitrite anion Chemical compound [O-]N=O IOVCWXUNBOPUCH-UHFFFAOYSA-M 0.000 description 1
- 208000012868 Overgrowth Diseases 0.000 description 1
- 235000019482 Palm oil Nutrition 0.000 description 1
- 241000191992 Peptostreptococcus Species 0.000 description 1
- 241000186429 Propionibacterium Species 0.000 description 1
- 241000192142 Proteobacteria Species 0.000 description 1
- 241000702670 Rotavirus Species 0.000 description 1
- 241000192031 Ruminococcus Species 0.000 description 1
- 241000293871 Salmonella enterica subsp. enterica serovar Typhi Species 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- 241000194020 Streptococcus thermophilus Species 0.000 description 1
- 235000006468 Thea sinensis Nutrition 0.000 description 1
- 208000037386 Typhoid Diseases 0.000 description 1
- 241001148134 Veillonella Species 0.000 description 1
- 235000005811 Viola adunca Nutrition 0.000 description 1
- 240000009038 Viola odorata Species 0.000 description 1
- 235000013487 Viola odorata Nutrition 0.000 description 1
- 235000002254 Viola papilionacea Nutrition 0.000 description 1
- 201000007096 Vulvovaginal Candidiasis Diseases 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 210000001789 adipocyte Anatomy 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 229930014669 anthocyanidin Natural products 0.000 description 1
- 235000008758 anthocyanidins Nutrition 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000000879 anti-atherosclerotic effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003217 anti-cancerogenic effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 235000019606 astringent taste Nutrition 0.000 description 1
- 230000008952 bacterial invasion Effects 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 229940002008 bifidobacterium bifidum Drugs 0.000 description 1
- 229940004120 bifidobacterium infantis Drugs 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000008827 biological function Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 235000019636 bitter flavor Nutrition 0.000 description 1
- 235000020279 black tea Nutrition 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000036952 cancer formation Effects 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 231100000357 carcinogen Toxicity 0.000 description 1
- 231100000504 carcinogenesis Toxicity 0.000 description 1
- 239000003183 carcinogenic agent Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 229930002875 chlorophyll Natural products 0.000 description 1
- 235000019804 chlorophyll Nutrition 0.000 description 1
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 1
- 229950001002 cianidanol Drugs 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 201000003146 cystitis Diseases 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 230000001877 deodorizing effect Effects 0.000 description 1
- 230000001066 destructive effect Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 235000020774 essential nutrients Nutrition 0.000 description 1
- 238000005562 fading Methods 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 229940057006 ferrous tartrate Drugs 0.000 description 1
- 150000002206 flavan-3-ols Chemical class 0.000 description 1
- 235000011987 flavanols Nutrition 0.000 description 1
- HVQAJTFOCKOKIN-UHFFFAOYSA-N flavonol Natural products O1C2=CC=CC=C2C(=O)C(O)=C1C1=CC=CC=C1 HVQAJTFOCKOKIN-UHFFFAOYSA-N 0.000 description 1
- 150000002216 flavonol derivatives Chemical class 0.000 description 1
- 235000011957 flavonols Nutrition 0.000 description 1
- NWKFECICNXDNOQ-UHFFFAOYSA-N flavylium Chemical compound C1=CC=CC=C1C1=CC=C(C=CC=C2)C2=[O+]1 NWKFECICNXDNOQ-UHFFFAOYSA-N 0.000 description 1
- 239000005428 food component Substances 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 230000007760 free radical scavenging Effects 0.000 description 1
- 229940074391 gallic acid Drugs 0.000 description 1
- 235000004515 gallic acid Nutrition 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 244000005709 gut microbiome Species 0.000 description 1
- 230000008821 health effect Effects 0.000 description 1
- 229910001385 heavy metal Chemical class 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 229940079322 interferon Drugs 0.000 description 1
- 208000028774 intestinal disease Diseases 0.000 description 1
- 210000002490 intestinal epithelial cell Anatomy 0.000 description 1
- RBTARNINKXHZNM-UHFFFAOYSA-K iron trichloride Chemical compound Cl[Fe](Cl)Cl RBTARNINKXHZNM-UHFFFAOYSA-K 0.000 description 1
- 229940039696 lactobacillus Drugs 0.000 description 1
- 229940004208 lactobacillus bulgaricus Drugs 0.000 description 1
- 229940046892 lead acetate Drugs 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000007721 medicinal effect Effects 0.000 description 1
- 150000004667 medium chain fatty acids Chemical class 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 244000000010 microbial pathogen Species 0.000 description 1
- 230000002906 microbiologic effect Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 210000000214 mouth Anatomy 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 239000010461 other edible oil Substances 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 239000002540 palm oil Substances 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000008855 peristalsis Effects 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 210000003240 portal vein Anatomy 0.000 description 1
- 239000012286 potassium permanganate Substances 0.000 description 1
- OTYBMLCTZGSZBG-UHFFFAOYSA-L potassium sulfate Chemical compound [K+].[K+].[O-]S([O-])(=O)=O OTYBMLCTZGSZBG-UHFFFAOYSA-L 0.000 description 1
- 229910052939 potassium sulfate Inorganic materials 0.000 description 1
- 235000011151 potassium sulphates Nutrition 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 238000006479 redox reaction Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 239000012266 salt solution Substances 0.000 description 1
- 208000026775 severe diarrhea Diseases 0.000 description 1
- 230000031068 symbiosis, encompassing mutualism through parasitism Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 108700012359 toxins Proteins 0.000 description 1
- DCXXMTOCNZCJGO-UHFFFAOYSA-N tristearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCC DCXXMTOCNZCJGO-UHFFFAOYSA-N 0.000 description 1
- 201000008297 typhoid fever Diseases 0.000 description 1
- 208000019206 urinary tract infection Diseases 0.000 description 1
- 210000001215 vagina Anatomy 0.000 description 1
- 235000019871 vegetable fat Nutrition 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 235000019168 vitamin K Nutrition 0.000 description 1
- 239000011712 vitamin K Substances 0.000 description 1
- 230000004584 weight gain Effects 0.000 description 1
- 235000019786 weight gain Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS, COOKING OILS
- A23D9/00—Other edible oils or fats, e.g. shortenings, cooking oils
- A23D9/007—Other edible oils or fats, e.g. shortenings, cooking oils characterised by ingredients other than fatty acid triglycerides
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS, COOKING OILS
- A23D9/00—Other edible oils or fats, e.g. shortenings, cooking oils
- A23D9/02—Other edible oils or fats, e.g. shortenings, cooking oils characterised by the production or working-up
- A23D9/04—Working-up
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The invention relates to the field of probiotic drops, more specifically, it relates to an oil-based probiotic
drops and a preparation method thereof. The probiotic drops of the present invention, wherein the oil
includes the following components by weight: 2.5-4.5g of olive oil, 4-8g of medium chain triglycerides;
and the following substances are also added: 0.08-0.2g of probiotics. The invention has the following
beneficial effects: the raw materials are medium-chain triglycerides with high stability and olive oil
containing a large amount of monounsaturated fatty acids, and the safety is high. Medium-chain
triglycerides can be broken down into human functions in a short time without forming fat accumulation in
the body. Olive oil can reduce the blood lipids and cholesterol in the human blood, prevent the occurrence
of cardiovascular and cerebrovascular diseases, and provide the human body with a variety of vitamins.
The preparation method of the oil agent provided by the invention is simple and easy to operate. The
stability of probiotics is higher than other products in the prior art.
Description
The invention relates to the field of probiotic drops, more specifically, it relates to an oil-based probiotic drops and a preparation method thereof. The probiotic drops of the present invention, wherein the oil includes the following components by weight: 2.5-4.5g of olive oil, 4-8g of medium chain triglycerides; and the following substances are also added: 0.08-0.2g of probiotics. The invention has the following beneficial effects: the raw materials are medium-chain triglycerides with high stability and olive oil containing a large amount of monounsaturated fatty acids, and the safety is high. Medium-chain triglycerides can be broken down into human functions in a short time without forming fat accumulation in the body. Olive oil can reduce the blood lipids and cholesterol in the human blood, prevent the occurrence of cardiovascular and cerebrovascular diseases, and provide the human body with a variety of vitamins. The preparation method of the oil agent provided by the invention is simple and easy to operate. The stability of probiotics is higher than other products in the prior art.
Probiotic drops and preparation method
The invention relates to the field of probiotic drops, more specifically, it relates to an oil-based probiotic drops and its preparation method.
Oil plays an indispensable role in human life. It is one of the six nutrients required by the human body and provides energy for human activities. Too much or too little intake of fats will affect the health of the human body and cause diseases. However, there are many types of edible oil on the market, and the composition ratio of different oils is different. The development of an oil agent that can supplement the nutrients required by the human body will have social significance and health care value. More than 99% of oil is fat, and fat contains different types of fatty acids. According to the structure of fatty acids, it can be divided into saturated fatty acids and unsaturated fatty acids. Most saturated fatty acids are derived from animal fats and a few vegetable fats, such as coconut oil and palm oil. Studies have shown that excessive intake of saturated fatty acids can lead to increased blood cholesterol, triacylglycerol and low-density lipoprotein cholesterol in the body, which may cause arterial stenosis, atherosclerosis, and increase the probability of coronary heart disease, is not conducive to the health of cardiovascular and cerebrovascular. Unsaturated fatty acids can be divided into monounsaturated fatty acids and polyunsaturated fatty acids. Contrary to saturated fatty acids, unsaturated fatty acids are involved in the synthesis of essential nutrients for the human body, such as DHA and EPA, which can effectively reduce the content of human cholesterol and triglycerides, increase the content of high-density lipoprotein cholesterol, and effectively control the level of human blood lipids. At the same time, reduce blood viscosity, it can also effectively enhance the body's immunity, protect the elasticity of blood vessels and prevent cardiovascular diseases. However, due to the presence of multiple unsaturated bonds in polyunsaturated fatty acids, their stability is worse than that of monounsaturated fatty acids, and they are prone to peroxidation by lipids. Olive oil is a kind of vegetable oil, rich in monounsaturated fatty acids. Saturated fatty acids in olive oil: monounsaturated fatty acids: polyunsaturated fatty acids are about 1.3:6.9:1, and the content of monounsaturated fatty acids in some olive oils can even reach more than 80%. It can reduce blood cholesterol, triglycerides and low-density lipoprotein cholesterol content, control blood viscosity, and protect cardiovascular and cerebrovascular health accidents. Due to its chemical structure, it also has high stability and is not easy to be peroxidized by lipids. Australian oil researchers found that even under heating conditions, the properties of olive oil are very stable, and the harmful polar compounds produced are half or less of other edible oils. In addition, olive oil is also rich in vitamins A, B, D, E, K and antioxidants, which are anti-aging for the human body, protect the skin, beauty, prevent bone fragility, improve the function of the digestive system, and remove free radicals in the body Has a positive effect.
Medium-chain triglycerides (MCT), as the name implies, are a kind of medium-chain fatty acids, which contain only a small amount of unsaturated fatty acids, so their stability is extremely high regardless of high temperature or low temperature. In addition, medium-chain triglycerides are easy to be digested and absorbed by the human body due to their small relative molecular weight and short carbon chain, and are easily compatible with other organic solvents, oils or fat-soluble vitamins. When MCT enters the human body, it can be rapidly hydrolyzed in the intestine, absorbed by the intestinal epithelial cells, and then enter the blood circulation through the hepatic portal vein. It is worth noting that MCT can enter the mitochondria to provide energy for oxidation and decomposition without the transport of the L-carnitine shuttle system, and because the shorter carbon chain cannot be used as a structural material for fat cells. In other words, MCT can supply energy to the body at any time without being stored as fat. Due to its special properties, medium-chain triglycerides have been clinically applied for more than 60 years. It can be used to help patients with fat indigestion prevent the occurrence of malnutrition and help obese patients control weight gain and weight loss. Studies have shown that 44% of diabetes, 23% of ischemic heart disease and some cancers are inextricably linked to obesity, so preventing obesity also prevents many other diseases from occurring to a certain extent. In addition to this accident, MCT can also improve the metabolism of human sugar, fat and cholesterol, and help the body relieve fatigue by providing a lot of energy. Most importantly, clinical studies and multiple animal experiments have proven that MCT has good tolerability and extremely high safety, and can be eaten with confidence.
Generally speaking, probiotics (Probiotics) refer to edible microorganisms that have a positive effect on the host (such as animals or humans) after consumption. They can adjust the intestinal flora, improve the human micro-ecological balance, and inhibit harmful pathogenic microorganisms in the human body. The active ingredients in the probiotic micro-ecological capsules are live probiotic bacteria. At present, common probiotic bacteria include lactic acid bacteria, bifidobacteria, Lactobacillus bulgaricus, Streptococcus thermophilus, etc. Commercial probiotic microecological preparations are mostly processed by compounding bacterial powder of a single bacterial species and auxiliary materials. After multiple processing of bacterial powder, the vitality of bacterial species decreases, which is not enough to achieve the expected health care effect.
Probiotics are living microorganisms. When used in humans or animals, they promote the health of the host by improving the intestinal microbial balance (Fuller, R. Probiotics for Humans and Animals, 1989, J. Appl. Microbiol. 66: 365-378 ). The literature records that probiotics include L. rhamnosus LGG, L. johnsonii (L. johnsonii) LAI, L. casei (L. casei) Shirota and Bifidobacterium lactis (Bifidobacterium lactis) BbI2. In addition, many other probiotics are described in the literature in the field (see, for example, M.E. Sanders & J.H. isn't Veld 1999. Antonie van
Leeuwenhoek 76:293-315, Kluwer Academic Publishers). The role of probiotics to promote health includes the balance and maintenance of the intestinal flora, the stimulation of the immune system and the anti-carcinogenic activity. The beneficial effects of probiotics in the human intestine are based on several factors caused by living bacterial cells, their cell structure and metabolites. Probiotics are usually administered in nutritional products or as capsules. If a certain kind of bacteria basically meets the following requirements, it can be called a probiotic, that is: it can maintain vitality under the harsh conditions generally in the digestive tract (low pH of the stomach, acidity of the digestive system, etc.); It can usually attached on to the intestinal wall; It is metabolized in the intestine; It is technically applicable (tolerable processing); It demonstrated clinically tested and reported health effects; and it is safe to eat (Lee, YK and Salminen, S. 1995 The coming era of probiotics,Trend Food Sci Technol, 6:241-245).
The intestine is a complex micro-ecosystem, in which there are billions of different types of microorganisms in the inner mucosa. The probiotics in the gastrointestinal tract help maintain the health of the host gastrointestinal tract. The host gastrointestinal tract provides the place and support needed by probiotic bacteria, and a variety of foods. In return, they provide the host with a variety of potential treatments, changing the destructive effect of gastrointestinal bacteria through antibiotics; helping digestion and inhibiting bacteria that cause diseases ; Treatment and prevention of diarrhea, including infectious diarrhea, especially rotavirus that causes diarrhea in children; treatment of so-called "harmful" biological overgrowth in the gastrointestinal tract; alleviation of symptoms of polar bowel syndrome, inflammatory bowel disease; prevention and
/ or reduce the recurrence of vaginal yeast infections, urinary tract infections, and bladder inflammation; improve the absorption and digestion of lactose in people with lactose intolerance; and enhance the compilation response. Because probiotics have many beneficial effects, probiotics need to be supplemented.
The human digestive tract contains a large number of bacteria that live in symbiosis with the host. The content of microorganisms varies greatly between different parts of the digestive tract. About % of all intestinal bacteria occur in the colon, which is the most important part of the intestine. It is estimated that more than 400 bacterial species are thriving in the colon. In addition to these, the intestine also contains microorganisms called temporary microorganisms (GRGibson and MBRoberfroid (editors) "Colonic Microbiota: Nutrition and Health" (Colonic Microbiota; Nutrition and Health.) Kluwer Academic Publisher, Dordrecht, 1999 ). The dominant probiotics species are as follows: Bacteroides, Bifidobacterium, Coprococcus, Peptostreptococcus, Eubacterium, and Ruminococcus. Lactobacillus, Streptococcus, Fusobacterium, Veillonella, Propionibacterium,and Enterobacteriaceae(have slightly fewer species). Some of these species are useful microorganisms, while others may even be harmful. The average microbial content in feces is 1012cfu/g (per dry matter). Bacteria degrade and ferment those food components that are not absorbed in the small intestine in the colon, and the body can use the fermentation end products absorbed by the small intestine. In addition to nutrition, the microbial balance in the colon is of great significance to human health (Tannock, G.W. 1998. Research on the intestinal microbiota: the prerequisites for the development of probiotics Int. Dairy J. 8: 527-533). Changes in the composition of the intestinal flora or a sudden decrease in its number (due to severe diarrhea, antibiotic treatment, etc.) will increase the infectivity of potential pathogenic species, which may cause serious consequences (onset of allergies, intestinal diseases, cancer). Probiotics that can be supplemented usually include: acidophilus, L. bulgaricus, L. plantarum, L. casei, Bifidobacterium bif idum, L. yeast , Lactobacillus rhamnosus (L.rhamnosus), Lactobacillus salivarius (L.salivarius), Bifidobacterium infantis (B.]nfantis), B.animal is subsp, lactis, long double Fidobacterium(B.longum), Streptococcus thermophilis, and Enterococcusfaecalis (Enterococcus faecalis) are all found in the human gastrointestinal tract and/or vagina. Lactic acid bacteria are gram-positive lactic acid bacteria, which absorb lactose and other monosaccharides in the intestinal tract and produce lactic acid, which helps to reduce the pH of the organs and makes the organ environment unfavorable for the production of harmful bacteria.
Tea polyphenols have a wide range of inhibitory effects on bacteria, and have obvious inhibitory effects on pathogenic bacteria such as typhoid bacillus, paratyphoid bacillus, staphylococcus aureus, dysentery, cholera, etc., with a concentration of 0.08% to 0.1%, against fungi and yeast, Lactic acid bacteria and acetic acid bacteria have no inhibitory effect. It can effectively inhibit the oral streptococcus mutants that causes dental caries in the oral cavity, and the effect of preventing dental caries is better than that of fluoride. In addition, tea polyphenols have biological functions such as anti-oxidation, anti-mutation, anti-cancer, anti-aging, scavenging free radicals, lowering blood pressure and cholesterol. Tea polyphenols have strong polarity and a certain degree of hydrophilicity. Natural antioxidants. When tea polyphenols meet ferric chloride, green-black or blue-black precipitates are formed, and some tea polyphenols meet gelatin to produce off-white precipitates. The effect of tea polyphenols and heavy metal salt solutions such as 1% aluminum trichloride or basic lead acetate in water produces a gray-yellow precipitate. It can also be oxidized by potassium permanganate, potassium sulfate and other oxidants, and form a blue-violet complex with ferrous tartrate. The main medicinal effects of tea polyphenols are: (1) Lower blood lipids and inhibit atherosclerosis. Many studies have shown that drinking tea can reduce the blood cholesterol content and has obvious anti-atherosclerosis function. This is because tea polyphenol compounds play an important role in the body's fat metabolism, inhibiting the increase in cholesterol levels in plasma and liver, and promoting the excretion of lipid compounds from feces. Therefore, it can not only prevent arteries Atherosclerosis, but also has the effect of weight loss. (2) Strengthen capillaries and lower blood sugar. Tea polyphenols can not only prevent the increase in microvascular permeability caused by excessive fat, but also work together with tea alkaloids to relax the blood vessel wall and increase the effective diameter, which is beneficial to the relaxation of human blood vessels and enhances the toughness of microvascular walls. Play a role in preventing rupture of blood vessels. Experiments show that catechins can also effectively lower blood sugar and reduce the risk of diabetes. (3) Radiation resistance. Regarding tea anti-radiation, it was first reported by Japan. They found that among the survivors of the nuclear bomb, those who drank tea frequently had less radiation sickness. A series of animal experiments show that tea polyphenols have obvious anti-radiation effects. It is generally believed that the anti-radiation effect of tea polyphenols is related to the participation of tea polyphenols in redox reactions in the body, protection of blood, repair of physiological functions, and inhibition of internal bleeding. In addition, tea polyphenols can reduce DNA damage caused by radiation. (4) Anti-aging. Lipid peroxidation in the human body is one of the mechanisms of human aging, and free radicals are the main factor of peroxidation in the organism. Tea polyphenols have a strong effect of scavenging free radicals, which can play an anti-oxidation and anti-aging effect. Animal experiments show that tea polyphenols can inhibit lipoxygenase activity and lipid peroxidation in skin mitochondria. (5) Anti-cancer and anti-mutation. Free radicals may play a certain role in the process of carcinogenesis, so the free radical scavenging effect of tea polyphenols can play an anti-cancer effect.
The purpose of the present invention is to provide a health-care probiotic containing a large amount of medium-chain triglycerides and olive oil, which helps the human body maintain health while reducing fat accumulation, helps the human body reduce blood fat and cholesterol levels, and supplements multiple vitamins. The preparation method provided by the invention is simple, the product tastes good, the nutritional components are easy to maintain, the stability is high, and the product shelf life is long. The purpose of the present invention is achieved through the following technical solutions: A health oil for strengthening human health, enhancing immunity and regulating the intestines and stomach. The oil comprises the following components by weight: 2.5-4.5g of olive oil, 4-8g of medium chain triglycerides, and the following substances are also added: Probiotics 0.08-0.2g; Preferably, 3g olive oil, 6.282g medium-chain triglycerides, and add the following substances: 0.12g of probiotics; Among them, the probiotics consists various bacteria, and the following ratios are preferred: M-16V Bifidobacterium breve 100B/g Among them, Equiv. to 5b cfu/bottle is equivalent to 50 billion CFU per bottle HNOO1 Lactobacillus rhamnosus 450B Among them, Equiv. to 15b cfu/bottle is equivalent to 150 billion CFU per bottle HNO19 Bifidobacterium lactis 300B cfu/g Among them, Equiv. to lOb cfu/bottle is equivalent to 100 billion CFU per bottle.
The combination ratio of the above-mentioned probiotics has been tested for many times. The combined probiotics can very well regulate the human intestines and stomach and increase immunity. The taste is also very good, and it is also very uniform after being mixed with olive oil. The above-mentioned selected probiotic combination, among them, Bifidobacterium breve can enhance the body's own ability to produce interferon, strengthen the body's own resistance, increase its own resistance, repair cells damaged by bacterial invasion or medical treatment, and enhance the vitality of life and quality. Bifidobacterium breve has an inhibitory effect on spoilage bacteria and pathogenic bacteria, pathogenic Escherichia coli, Staphylococcus aureus, Shigella dysentery, Salmonella typhi, and Proteobacteria. It will gradually decrease with age, and bad diet or living habits will greatly reduce the amount of Bifidobacterium breve. Lactobacillus rhamnosus is a non-toxic and non-side-effect probiotic. Its functional properties mainly include regulation of intestinal flora, prevention and treatment of diarrhea, excretion of toxins and enhancement of body immunity. It has high application value and conforms to the basic needs of modem human health care. Bifidobacterium and lactic acid bacteria and other beneficial bacteria can inhibit the growth of harmful bacteria in the human body, resist the infection of pathogenic bacteria, synthesize vitamins needed by the human body, promote the absorption of minerals by the human body, and produce organic acid stimulation such as acetic acid, propionic acid, butyric acid and lactic acid Intestinal peristalsis, promote defecation, prevent constipation, inhibit intestinal corruption, purify the intestinal environment, decompose carcinogens, stimulate the human immune system, and thus play an important role in improving disease resistance.
The oil also includes 0.0024-0.006 g of tea polyphenols.
The tea polyphenols preferably used in the present invention are powdered solids. The properties of the preferred tea polyphenols are as follows: light yellow to brown tea-flavored aqueous solution, powdered solid or crystal, with astringent taste, easily soluble in water and ethanol, Ethyl acetate, slightly soluble in fat. It has good heat resistance and 5 acid resistance, and it is very stable in the range of pH=2-7. Slightly hygroscopic, pH of aqueous solution=3-4. It is easy to oxidize and brown under alkaline conditions. Catechins account for about 60% to 80% of the total amount of tea polyphenols. Among the polyphenols extracted from green tea and its by-products, the content of tea polyphenols is greater than 95%, of which catechins 70%~80%; flavonoids
4%~10%; gallic acid 0. 3 %-0.5%;Amino acid 0. 2 %-0.5%;total sugar content 0.5%~1.0%. Chlorophyll is mainly pheophytin, with a content of 0.01% to 0.05%. Tea polyphenols have a strong antioxidant effect, especially the ester-type catechin EGCG, whose reduction can even reach 100 times that of L-isocorbic acid. Among the four main catechin compounds, the antioxidant capacity is EGCG>EGC>ECG>EC>BHA, and the antioxidant capacity increases with the increase of temperature. In addition to antioxidant effects, tea polyphenols also have antibacterial effects, such as inhibitory effects on Staphylococcus,
Escherichia coli and Bacillus subtilis. Tea polyphenols can absorb peculiar smell in food, so it has a certain deodorizing effect. It has a protective effect on the pigment in food. It can not only play the role of natural pigment, but also prevent food from fading. Tea polyphenols also have the effect of inhibiting the formation and accumulation of nitrite. One of the highlight of this inventions is that, the addition of tea polyphenols protects the oil base of olive oil and further protects other nutrients added to the oil base. Generally, a simple mixing method can be used for mixing. For example, the following preparation method of health oil for strengthening human health, enhancing immunity and regulating the intestines and stomach includes the following steps: 1) Weigh all the raw materials according to the above-mentioned weight ratio for use. 2) Mix olive oil and medium-chain triglycerides (preferably, tea polyphenols can also be added at the same time), mix them evenly by stirring, and place them at 30°C-35°C for later use. 3) The mixture obtained in step (2) is filtered through a precision filter and then canned into a bottle. 4) Put the finished product obtained in step (3) into an ultraviolet sterilization device for sterilization. Preferably, the inventors creatively improved the processing method to further improve the stability of the final product: Before mixing olive oil and MCT, premix MCT and tea polyphenols. This step is very important. Otherwise, problems of poor anti-oxidation effect and uneven mixing will occur. The specific operation methods are as follows: ) MCT and tea polyphenols are mixed under vacuum at room temperature (for example, from °C to 30C); preferably, the appropriate vacuum pressure is less than 7 Torr; preferably, the tea polyphenols are milled to an average particle size of about 10 pm to about 1000pm powder belongs to the preferred addition range of the present invention; 6) In order to maximize the stability of the final product, it is preferable to reduce the water activity of the oil agent after mixing to Aw less than 0.1 or lower; 7) Then it is heated to 40-50°C and kept for 60-120 minutes after one time; 8) After cooling down to room temperature, set aside, and mix with olive oil and probiotics. The pre-mixing method is an important invention of the present invention. This is because after the powder and oil are fully mixed at room temperature, there is a cross-linking time. After testing, just mixing at room temperature does not guarantee a long time. After precipitation, after many tests, after heating up and maintaining a period of time, the final product will maintain a uniform state for a long time, and it has a very good effect to maintain the consistency of the final product. In the above method, preferably, the first) above is treated at 20-100 rpm for 5-50 minutes. After many tests, the effect of simple stirring and mixing is far inferior to regular stirring. In summary, the present invention has the following beneficial effects: (1) The raw materials are medium-chain triglycerides with high stability and olive oil containing a large amount of monounsaturated fatty acids, which has high safety.
(2) Medium-chain triglycerides can be decomposed into human body functions in a short time without forming fat accumulation in the body. (3) Olive oil can reduce blood lipids and cholesterol in human blood, prevent cardiovascular and cerebrovascular diseases, and provide a variety of vitamins for the human body. (4) The preparation method of the oil agent provided by the present invention is simple and easy to operate. (5) The activity and stability of probiotics are protected to the greatest extent. Thanks to the joint action of olive oil and tea polyphenols, the antioxidant properties of tea polyphenols make olive oil very good in antioxidant properties. The joint action protects the stability of probiotics. Tea polyphenols being the antioxidant, which further protects olive oil from being oxidized. High quality olive oil can further protect nutrients from damage and maximize the shelf life of the product; tea polyphenols refer to the compound made up from catechins(flavanols), flavonoids and flavonols, anthocyanidins, phenolic acid and depsilic acid polyphenol compounds, regarding their structures, except for phenolic acid and depsilic acid, they both have 2- C6-C3-C6 basic carbon framework with phenylchroman (flavan) as the main body, of which catechin compounds are the main components of tea polyphenols, accounting for about 50% of the total tea polyphenols~ 70%, accounting for 12% to 24% of the dry weight of tea, is a kind of compound with a relatively complex structure, including catechins, gallocatechins, gallocatechin gallate, catechin gallate, etc. The content of tea polyphenols in tea is roughly that green tea is more than black tea, and summer and autumn tea are more than spring tea.
DETAILED DESCRIPTION OF THE INVENTION The embodiments of the present invention are intended to be illustrative, and not to limit the scope of the present invention. Any slight difference in nutrient composition due to the difference in milk source should not be used as a reason for the inconsistency between the embodiment of the present invention and the specification, so the present invention aims to protect the purpose of adding nutrients, rather than to make the ratio particularly strict. The ground is limited to a specific value. In the following, the present invention will be further described in conjunction with the embodiments: Example 1 A health oil for strengthening human health, enhancing immunity and regulating the intestines and stomach. The oil comprises the following components by weight: 3g olive oil, 6.282g medium chain triglycerides, and the following substances are added: 0.12g probiotics ; The preparation method of the health oil for strengthening human health, enhancing immunity and regulating intestines and stomach includes the following steps: (1) Weigh all the raw materials according to the above-mentioned parts by weight ratio. (2) Mix olive oil and medium-chain triglycerides evenly, and place them at 32.5 °C for later use.
(3) The mixture obtained in step (2) is filtered through a precision filter and then canned and bottled. (4) Put the finished product obtained in step (3) into an ultraviolet sterilizer for sterilization. Before mixing olive oil and MCT, premix MCT and tea polyphenols. This step is very important. Otherwise, problems of poor anti-oxidation effect and uneven mixing will occur. The specific operation methods are as follows: 1) MCT and 0.004 tea polyphenols are mixed at room temperature (25C) under vacuum; 2) Then it is heated to 45°C for 90 minutes after one time; 3) After cooling down to room temperature, set aside, and mix with olive oil and probiotics. Example 2 A health oil for strengthening human health, enhancing immunity and regulating the intestines and stomach. The oil comprises the following components by weight: 2.5 g of olive oil, 4 g of medium chain triglycerides, and the following substances are added: probiotics 0.08 g; The preparation method of the health oil for strengthening human health, enhancing immunity and regulating intestines and stomach includes the following steps: (1) Weigh all the raw materials according to the above-mentioned parts by weight ratio. (2) Mix olive oil and medium-chain triglycerides evenly, and place them at 30°C for later use. (3) The mixture obtained in step (2) is filtered through a precision filter and then canned and bottled. (4) Put the finished product obtained in step (3) into an ultraviolet sterilizer for sterilization. Preferably, the inventors creatively improved the processing method to further improve the stability of the final product: Before mixing olive oil and MCT, premix MCT and tea polyphenols. This step is very important. Otherwise, problems of poor anti-oxidation effect and uneven mixing will occur. The specific operation methods are as follows: 1) MCT and tea polyphenols are mixed under vacuum at room temperature (20°C) and 50 rpm for minutes; preferably, the appropriate vacuum pressure is lower than 7 Torr; preferably, the tea polyphenols are milled to an average particle size of about 500tm The powder belongs to the preferred addition range of the present invention; 2) In order to maximize the stability of the final product, it is preferable to reduce the water activity of the oil agent after mixing to Aw less than 0.1 or lower; 3) Then it is raised to 40°C for 60 minutes after one time; 4) After cooling down to room temperature, set aside, and mix with olive oil and probiotics. Example 3 A health oil for strengthening human health, enhancing immunity and regulating the intestines and stomach, the oil comprising the following components by weight: 4.5 g of olive oil, 8 g of medium chain triglycerides, and the following substances: probiotics 0.2 g; The preparation method of the health oil for strengthening human health, enhancing immunity and regulating intestines and stomach includes the following steps:
(1) Weigh all the raw materials according to the above-mentioned parts by weight ratio. (2) Mix olive oil and medium-chain triglycerides evenly, and place them at 33°C for later use. (3) The mixture obtained in step (2) is filtered through a precision filter and then canned and bottled. (4) Put the finished product obtained in step (3) into an ultraviolet sterilizer for sterilization. Before mixing olive oil and MCT, premix MCT and tea polyphenols. This step is very important. Otherwise, problems of poor anti-oxidation effect and uneven mixing will occur. The specific operation methods are as follows: 1) MCT and 0.006 g of tea polyphenols are mixed at room temperature (23°C) under vacuum; 2) Then it is heated to 43°C for 70 minutes after one time; 3) After cooling down to room temperature, set aside, and mix with olive oil and probiotics.
Example 4 A health oil for strengthening human health, enhancing immunity and regulating the intestines and stomach. The oil comprises the following components by weight: 4.5 g of olive oil, 4 g of medium chain triglycerides, and the following substances: probiotics 0.2 g;
The preparation method of the health oil for strengthening human health, enhancing immunity and regulating intestines and stomach includes the following steps: (1) Weigh all the raw materials according to the above-mentioned parts by weight ratio. (2) Mix olive oil and medium-chain triglycerides evenly and place them at 34°C for later use. (3) The mixture obtained in step (2) is filtered through a precision filter and then canned and bottled. (4) Put the finished product obtained in step (3) into an ultraviolet sterilizer for sterilization. Before mixing olive oil and MCT, premix MCT and tea polyphenols. This step is very important. Otherwise, problems of poor anti-oxidation effect and uneven mixing will occur. The specific operation methods are as follows: 1) MCT and 0.0024g tea polyphenols are mixed at room temperature (28C) under vacuum; 2) Then, it is heated to 48°C for 110 minutes after one time; 3) After cooling down to room temperature, set aside, and mix with olive oil and probiotics. Example 5 A health oil for strengthening human health, enhancing immunity and regulating the intestines and stomach. The oil includes the following components by weight: 3.5 g of olive oil, 5 g of medium chain triglycerides, and the following substances are also added: probiotics 12 g; The preparation method of the health oil for strengthening human health, enhancing immunity and regulating intestines and stomach includes the following steps: (1) Weigh all the raw materials according to the above-mentioned parts by weight ratio. (2) Mix olive oil and medium-chain triglycerides evenly, and place them at 35 °C for later use. (3) The mixture obtained in step (2) is filtered through a precision filter and then canned and bottled. (4) Put the finished product obtained in step (3) into an ultraviolet sterilizer for sterilization. Preferably, the inventors creatively improved the processing method to further improve the stability of the final product: Before mixing olive oil and MCT, premix MCT and tea polyphenols. This step is very important. Otherwise, problems of poor anti-oxidation effect and uneven mixing will occur. The specific operation methods are as follows: 1) MCT and 0.003 g of tea polyphenols are mixed under vacuum at room temperature (30°C) at 100 rpm for 50 minutes; preferably, the tea polyphenols are milled into powder with an average particle size of about 1000 tm, which belongs to the preferred addition range of the present invention; 2) In order to maximize the stability of the final product, it is preferable to reduce the water activity of the oil agent after mixing to Aw less than 0.1 or lower; 3) Then it is raised to 50°C for 120 minutes after one time; 4) After cooling down to room temperature, set aside, and mix with olive oil and probiotics. Product Sensory Evaluation: With reference to the sensory evaluation standard of edible oil, sensory evaluation was performed on the oil agents of Examples 1-3 and Comparative Examples of the present invention. Fifty consumers are randomly selected for sensory evaluation. The evaluation adopts a blind evaluation method. The evaluation criteria are shown in Table 1: Table 1 Sensory evaluation standards of health oil Test item Score Feature Description 1 Dislike very much 2 dislike The smell of oil 3 general 4 like 5 Like very much 1 Dislike very much 2 dislike Overall preference 3 general 4 like 5 Like very much The evaluation scores are averaged, and the results are shown in Table 2. Table 2 shows the sensory evaluation results of the oils prepared in Examples 1-3 and Comparative Examples: Table 2: The present invention is the sensory evaluation results of the oils prepared in Examples 1-3 and Comparative Examples of the present invention
Smell of oil overall preference Example1 4.29 4.27 Example2 4.38 4.37 Example3 4.42 4.49 Comparative example 4.02 4.01
It can be seen from Table 2 that the sensory evaluation odor of the oil preparations prepared in Examples 1-3 is 4.36 points, and the overall preference is 4.38 points. About the stability test: We have done long-term stability test (shelf life and room temperature retention sample) and accelerated test (6 months), which fully meets the standard requirements. The samples were stored under different conditions, the temperature varies from 4 degrees to 50 degrees, and different light conditions; evaluate the products at different time intervals, typically 2, 4, 8 and 12 weeks, do the microbiological challenge test; determine the sample If the sample remains unchanged for 8 weeks at high temperature, it should be stable for 1 year at room temperature. Sensory evaluation: Table 1 is the scoring standard for the uniformity of probiotics and the taste of the final product
Scoring criteria score Grade Uniformity odor Sinking time 510 seconds; number of white spots<10; Probiotics have a
unique fragrance, the 10 Very no white spots on the cup wall; no clumps good smell is natural without bitterness 11 seconds S sinking time S 20 seconds; a small The special
frankincense of 8-9 Good amount of small white spots, small particles; the number of small white spots and flakes on the cup probiotics is not wall < 10; 1 < clumpsS 5; small clumps strong, slightly bitter 21 seconds S sinking time 5 30 seconds; a small The frankincense amount of small white spots, small particles around characteristic of the small white spots; a small amount of small white probiotics is not 6-7 general spots and flakes on the wall of the cup; 1 5 clump<S 5; strong, with a slight large clumps vegetable oil taste and a slight bitter taste 31 seconds < sinking time 5 40 seconds; a large There are other
peculiar smells, 3-5 not number of small white spots and flakes, no obvious good difference between the middle and the surrounding relatively strong area; 6:5 clumpsK 10; clumps are larger bitter flavour 41 seconds S sinking time; a large number of small The milk smell is not very white spots and flakes, there is no obvious difference strong and there are <3 ver between the middle and the surrounding; 11 < clumps; there are a large number of small white spots and other smells, flakes on the wall of the cup that do not fall strong bitterness
According to the above criteria, the scores of Examples 1-3 of the present invention are as follows:
Table 2 Table 2 Scores of the embodiment of the present invention (25 people in the evaluation group, average scores, individual detail scores are not attached due to space limitations, only the average score with two decimal places after the decimal point is attached) Score
Uniformity smell Example 1 9.28 9.56 Example 2 9.19 9.59 Example 3 9.31 9.48
The above are only preferred embodiments of the present invention and are not intended to limit the present invention in other forms. Anyone familiar with the profession may use the technical content disclosed above to change or modify the equivalent of equivalent changes. However, any simple modifications, equivalent changes and modifications made to the above embodiments according to the technical essence of the present invention without departing from the content of the technical solution of the present invention still belong to the protection scope of the technical solution of the present invention.
Claims (5)
- CLAIM 1. A probiotic drop, characterized in that: the oil includes the following components by weight: 2.5-4.5 g of olive oil and 4-8 g of medium chain triglycerides; The following substances are also added: 0.08-0.2g of probiotics.
- 2. The probiotic drops according to claim 1, characterized in that: preferably, olive oil 3g, medium chain triglycerides 6.282g, and probiotics 0.12g.
- 3. The probiotic drops according to claim 1, wherein the oil further comprises 0.0024-0.006g of tea polyphenols.
- 4. The preparation method of probiotic drops according to claim 1 or 2, characterized in that: the preparation method comprises the following steps: 1) Weigh all the raw materials according to the above-mentioned weight ratio for use; 2) Mix olive oil and medium-chain triglycerides (preferably, tea polyphenols can also be added at the same time), mix them evenly by stirring, and place them at 30°C-35°C for later use; 3) The mixture obtained in step (2) is filtered through a precision filter and then canned into a bottle; 4) Put the finished product obtained in step (3) into an ultraviolet sterilization device for sterilization.
- 5. The preparation method of probiotic drops according to claim 3, characterized in that: Before mixing olive oil and MCT, premix MCT and tea polyphenols, the specific operation method is as follows: 1) MCT and tea polyphenols are mixed under vacuum at room temperature (for example, ranging from 20°C to 30°C); preferably, the appropriate vacuum pressure is less than 7 Torr; preferably, the tea polyphenols are milled to an average particle size of about The powder of 10 tm to about 1000 tm belongs to the preferred addition range of the present invention; 2) In order to maximize the stability of the final product, it is preferable to reduce the water activity of the oil agent after mixing to Aw less than 0.1 or lower; 3) Then it is raised to 40-50°C and kept for 60-120 minutes after one time; 4) After cooling down to room temperature, set aside, and mix with olive oil and probiotics.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2021101165A AU2021101165A4 (en) | 2021-03-04 | 2021-03-04 | Mushroom oil drops and its preparation method |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2021101165A AU2021101165A4 (en) | 2021-03-04 | 2021-03-04 | Mushroom oil drops and its preparation method |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2021101165A4 true AU2021101165A4 (en) | 2021-05-06 |
Family
ID=75714268
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2021101165A Active AU2021101165A4 (en) | 2021-03-04 | 2021-03-04 | Mushroom oil drops and its preparation method |
Country Status (1)
Country | Link |
---|---|
AU (1) | AU2021101165A4 (en) |
-
2021
- 2021-03-04 AU AU2021101165A patent/AU2021101165A4/en active Active
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TWI463986B (en) | New use of lactobacillus plantarum cmu995 strain | |
CN112716982B (en) | Lactic acid bacteria-containing composition and use thereof | |
CN112971145A (en) | Probiotic drop and preparation method thereof | |
CN113925923B (en) | Anti-acne and whitening compound probiotic composition and preparation method thereof | |
EP4048299B1 (en) | Probiotic composition for use as an antioxidant | |
AU2019201637A1 (en) | Compositions Comprising a Mixture of Bacteria Comprising Pediococcus and Lactobacillus and Methods for Decreasing the Effects of Alcohols | |
CN111034891A (en) | Solid beverage containing probiotic composition and preparation method thereof | |
JP2011116666A (en) | Anti-stress agent containing lactic bacterium-fermented royal jelly and method for producing the same | |
Onyenweaku et al. | Research Article Health Benefits of Probiotics | |
JP2016521287A6 (en) | Composition comprising a mixture of bacteria comprising Pediococcus and Lactobacillus, and method for reducing the effects of alcohol | |
El-Sayed et al. | Facile green preparation of Cr2O3 nanoparticles combined with probiotics in hydro-beads to produce integrated yoghurt | |
JP2005013211A (en) | Lactobacillus-containing food composition | |
CN108936607A (en) | Chronic Obstructive Pulmonary Disease full nutrition formula food | |
AU2021101165A4 (en) | Mushroom oil drops and its preparation method | |
JP2006055145A (en) | Pet food and method for offering the same | |
NZ773159A (en) | Probiotic drops and preparation method | |
CA3209558A1 (en) | Oral dose compositions of tributyrin for the therapeutic generation of butyrate in the gut | |
Agbakoba | Essentials of nutraceuticals and probiotics | |
KR102133015B1 (en) | Health functional food composition for prevention of diabetes | |
Molan et al. | Blueberries: Genotype-dependent variation in antioxidant, free-radical scavenging, and prebiotic activities | |
Yan et al. | Research progress on the effects of dietary factors on the bioavailability of polyphenol | |
ALZahrani | Microbial Analysis, Antioxidant and in vivo Anti-colitis Activities of Dairy and non-Dairy Plant-Based Milk Fermented with Probiotic Bacteria | |
Manoppo et al. | Cookies High in Antioxidants from the Combination of Lactobacillus Reuteri with Papaya Juice as a Functional Food Candidate for Children with Functional Digestive Problems | |
Hati et al. | Methods for improving survival of probiotics against harsh environments | |
Patel et al. | Diet-Derived Post-Biotic Metabolites to Promote Microbiota Function and Human Health |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FGI | Letters patent sealed or granted (innovation patent) |